John Lechleiter, chief operating officer of Eli Lilly & Co., talks with Bloomberg's Betty Liu from Indianapolis about the company's fourth-quarter profit reported today, drug pipeline and acquisition strategy. Eli Lilly, the world's biggest maker of psychiatric drugs, said net income rose more than sixfold to $854.4 million, or 78 cents a share, on increased sales of the antidepressant Cymbalta and impotency pill Cialis. Lechleiter becomes the company's chief executive officer on April 1. (Source: Bloomberg)